Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.42 USD | -4.66% | +15.05% | +118.20% |
Financials (USD)
Sales 2024 * | 1.22B | Sales 2025 * | 1.53B | Capitalization | 4.17B |
---|---|---|---|---|---|
Net income 2024 * | 39M | Net income 2025 * | 68M | EV / Sales 2024 * | 3.24 x |
Net cash position 2024 * | 217M | Net cash position 2025 * | 418M | EV / Sales 2025 * | 2.46 x |
P/E ratio 2024 * |
120
x | P/E ratio 2025 * |
65.8
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.13% |
Latest transcript on Hims & Hers Health, Inc.
1 day | -4.66% | ||
1 week | +15.05% | ||
1 month | +54.99% | ||
3 months | +48.93% | ||
6 months | +118.45% | ||
Current year | +118.20% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 38 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 83 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 19.42 | -4.66% | 15,992,201 |
24-05-30 | 20.37 | +4.03% | 19,129,122 |
24-05-29 | 19.58 | +2.51% | 12,412,546 |
24-05-28 | 19.1 | +13.15% | 21,134,206 |
24-05-24 | 16.88 | +6.63% | 10,022,632 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.20% | 4.17B | |
-47.84% | 1.91B | |
+78.57% | 584M | |
+3.15% | 445M | |
-71.35% | 127M | |
-25.18% | 94.34M |
- Stock Market
- Equities
- HIMS Stock